Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

ClinicalTrials.gov ID: NCT05612100

Public ClinicalTrials.gov record NCT05612100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 9:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Endocrine Therapy-Induced Alopecia Natural History Evaluation Among Female Breast Cancer Survivors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluates endocrine therapy-induced alopecia among postmenopausal and premenopausal female patients with breast cancer. Alopecia is one of the most feared side effects of cancer-directed therapy, causing distress in women starting treatment for breast cancer. While alopecia is a well-known side effect of many chemotherapy drugs, it has also been reported by women undergoing endocrine therapy. Despite the frequent reports of alopecia related to endocrine therapy, hair loss is rarely reported as a side effect of endocrine therapy and the exact characterization of alopecia is not well understood. By having postmenopausal and premenopausal breast cancer patients describe their hair loss symptoms experienced while undergoing endocrine therapy, researchers may be able to better characterize the incidence, timing, duration, and severity of alopecia and whether the different types of endocrine therapy cause more or less trouble in this regard.

Study identification

NCT ID
NCT05612100
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Mayo Clinic
Other
Enrollment
169 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2022
Primary completion
Jul 8, 2028
Completion
Jul 8, 2028
Last update posted
Jul 20, 2026

2022 – 2028

United States locations

U.S. sites
23
U.S. states
1
U.S. cities
22
Facility City State ZIP Site status
Mayo Clinic Health System in Albert Lea Albert Lea Minnesota 56007
Essentia Health Baxter Clinic Baxter Minnesota 56425
Sanford Joe Lueken Cancer Center Bemidji Minnesota 56601
Essentia Health Saint Joseph's Medical Center Brainerd Minnesota 56401
Essentia Health - Deer River Clinic Deer River Minnesota 56636
Essentia Health Saint Mary's - Detroit Lakes Clinic Detroit Lakes Minnesota 56501
Essentia Health Cancer Center Duluth Minnesota 55805
Essentia Health Ely Clinic Ely Minnesota 55731
Essentia Health - Fosston Fosston Minnesota 56542
Fairview Grand Itasca Clinic & Hospital Grand Rapids Minnesota 55744
Essentia Health Hibbing Clinic Hibbing Minnesota 55746
Fairview Range Medical Center Hibbing Minnesota 55746
Essentia Health - International Falls Clinic International Falls Minnesota 56649
Mayo Clinic Health Systems-Mankato Mankato Minnesota 56001
MMCORC CentraCare Monticello Cancer Center Monticello Minnesota 55362
Essentia Health Moose Lake Moose Lake Minnesota 55767
Essentia Health - Park Rapids Park Rapids Minnesota 56470
Fairview Northland Medical Center Princeton Minnesota 55731
Mayo Clinic in Rochester Rochester Minnesota 55905
Essentia Health Sandstone Sandstone Minnesota 55072
Sanford Health Thief River Falls Thief River Falls Minnesota 56701
Essentia Health Virginia Clinic Virginia Minnesota 55792
Sanford Health Worthington Worthington Minnesota 56187

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05612100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2026 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05612100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →